Both GLP-1RA and SGLT-2 inhibitors were associated with a lower risk (10% and 31%, respectively) as compared with placebo, and an even greater lower risk as compared with DPP-4 inhibitors (15% and 35%, respectively)
After a 2-week placebo run-in period, patients who had a seated systolic blood pressure of 135 mm Hg or more were assigned to receive baxdrostat (1 mg or 2 mg) or placebo once daily for 12 weeks
Contraindications and Precautions While semaglutide is promising, its not suitable for everyone
Some users report uneven skin tone , darker freckles, or patches that appear more pronounced than others
19 We speculate that patients with clEDS may be more prone to have structural defects along the walls of the gastrointestinal tract, which can predispose to diffuse diverticulosis, diverticulitis, and resulting bowel perforation as well as to perforation during invasive procedures and spontaneous perforation
These symptoms may occur in the first few weeks or months of use but often fade after your body has adjusted to the medication